Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Can progesterone treat premenstrual syndrome? Poor research methods leaves important question unanswered

18.10.2006
Progesterone may help some women with premenstrual syndrome (PMS), but flaws in many of the trials that set out to test this therapy mean that we still don’t know.

Five in every one hundred women suffer premenstrual symptoms at some time in their lives that are severe enough to interfere with their lives. One possible cause of the symptoms is the drop in progesterone that comes before menstruation. A suggested treatment, therefore, is to give women extra progesterone. But many health professionals doubt whether this treatment works.

To see if the research evidence can help resolve this, Cochrane Review Authors examined 17 different studies before performing a more detailed analysis of the data from the two trials which met their eligibility criteria. Of these, one trial of ‘better quality’ concluded that progesterone was more effective than placebo.

The main problem with assessing the benefit of progesterone is that 15 of the 17 trials had to be excluded for one or more important reasons. Some did not screen women for psychiatric disorders or persistence of symptoms after their menstrual periods, and others had to be excluded because the diagnosis of PMS was based on less than two cycles of symptom records. Probably because they needed to be run over many months, many trials also had a high drop out rate.

“The Review has revealed more about the difficulties inherent in the study of PMS and consequent deficiencies in method, than about the efficacy of progesterone in treating it,” says Lead Review Author Olive Ford former honorary Research Officer for the National Association for Premenstrual Syndrome.

Knowing whether progesterone is a useful treatment is complicated by the fact that treatments for PMS generally show large placebo effects. The Review Authors describe how some trials involving other therapies have found the placebo to have more effect than the treatment.

The Review points out that any women who do use progesterone need to be told of the mild side effects. These can include changes in menstrual cycle length and a tendency to become drowsy. In addition one woman who had believed herself to be infertile, conceived when taking progesterone, out of a total of about 650 women in all the trials examined.

Polly Young | alfa
Further information:
http://www.thecochranelibrary.com

More articles from Health and Medicine:

nachricht Purdue cancer identity technology makes it easier to find a tumor's 'address'
16.11.2018 | Purdue University

nachricht Microgel powder fights infection and helps wounds heal
14.11.2018 | Michigan Technological University

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: UNH scientists help provide first-ever views of elusive energy explosion

Researchers at the University of New Hampshire have captured a difficult-to-view singular event involving "magnetic reconnection"--the process by which sparse particles and energy around Earth collide producing a quick but mighty explosion--in the Earth's magnetotail, the magnetic environment that trails behind the planet.

Magnetic reconnection has remained a bit of a mystery to scientists. They know it exists and have documented the effects that the energy explosions can...

Im Focus: A Chip with Blood Vessels

Biochips have been developed at TU Wien (Vienna), on which tissue can be produced and examined. This allows supplying the tissue with different substances in a very controlled way.

Cultivating human cells in the Petri dish is not a big challenge today. Producing artificial tissue, however, permeated by fine blood vessels, is a much more...

Im Focus: A Leap Into Quantum Technology

Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.

In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...

Im Focus: Research icebreaker Polarstern begins the Antarctic season

What does it look like below the ice shelf of the calved massive iceberg A68?

On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.

Im Focus: Penn engineers develop ultrathin, ultralight 'nanocardboard'

When choosing materials to make something, trade-offs need to be made between a host of properties, such as thickness, stiffness and weight. Depending on the application in question, finding just the right balance is the difference between success and failure

Now, a team of Penn Engineers has demonstrated a new material they call "nanocardboard," an ultrathin equivalent of corrugated paper cardboard. A square...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

“3rd Conference on Laser Polishing – LaP 2018” Attracts International Experts and Users

09.11.2018 | Event News

On the brain’s ability to find the right direction

06.11.2018 | Event News

European Space Talks: Weltraumschrott – eine Gefahr für die Gesellschaft?

23.10.2018 | Event News

 
Latest News

Purdue cancer identity technology makes it easier to find a tumor's 'address'

16.11.2018 | Health and Medicine

Good preparation is half the digestion

16.11.2018 | Life Sciences

Microscope measures muscle weakness

16.11.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>